US 12,343,385 B2
Hemostat reconstitution methods and devices
Yves Delmotte, Neufmaison (BE)
Assigned to Baxter International Inc., Deerfield, IL (US); and Baxtter Healthcare SA, Glattpark (CH)
Filed by BAXTER INTERNATIONAL INC., Deerfield, IL (US); and BAXTER HEALTHCARE SA, Glattpark (CH)
Filed on Nov. 11, 2022, as Appl. No. 17/985,427.
Claims priority of provisional application 63/283,781, filed on Nov. 29, 2021.
Prior Publication US 2023/0165944 A1, Jun. 1, 2023
Int. Cl. A61K 38/48 (2006.01); A61L 24/00 (2006.01)
CPC A61K 38/4833 (2013.01) [A61L 24/0031 (2013.01); A61L 2400/04 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A system for administering a hemostatic material to a patient, the system comprising;
a first syringe co-loaded with at least one substrate material and at least one hemostatic agent including a membrane separating said substrate material and said hemostatic agent; and
a second syringe loaded with a diluent.